Related Experiment Video
Updated: May 5, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Key Articles and Guidelines in the Management of Chronic Coronary Disease
Dave L Dixon1, Tomasz Jurga2, Michael Kelly3
1Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University School of Pharmacy, Richmond, VA, USA.
Insights
Advances in managing cardiovascular events lead to more patients needing chronic care for chronic coronary disease (CCD). New guidelines and pharmacotherapies are crucial for preventing future cardiac events in these patients.
Area of Science:
- Cardiology
- Cardiovascular Medicine
- Clinical Practice Guidelines
Background:
- Cardiovascular disease is a leading cause of mortality.
- Improved acute event management increases the population requiring chronic care.
- Stable ischemic heart disease (SIHD) is now termed chronic coronary disease (CCD).
Purpose of the Study:
- To summarize key articles and guidelines for chronic coronary disease (CCD) management.
- To provide a resource for clinicians caring for patients with CCD.
- To highlight the expanded role of pharmacotherapy in CCD.
Main Methods:
- Review of recent clinical trials and novel drug therapies.
- Consolidation of prior guidelines on secondary prevention and SIHD management.
- Synthesis of evidence impacting pharmacotherapy for CCD.
Main Results:
- The 2023 CCD guidelines consolidate previous recommendations.
- Pharmacotherapy plays an increasingly significant role in CCD management.
- Emerging evidence supports expanded therapeutic options for CCD.
Conclusions:
- Clinicians require updated resources for managing chronic coronary disease.
- Pharmacotherapy is a cornerstone of secondary prevention in CCD.
- Adherence to updated guidelines is essential for optimal patient outcomes.
Abstract:
Cardiovascular disease remains the leading cause of death; however, advances in the acute management of cardiovascular events have resulted in a greater number of patients who require chronic management to prevent future events. The care of these patients in the post-acute care phase was historically referred to as stable ischemic heart disease (SIHD) but is now collectively referred to as chronic coronary disease (CCD). In 2023, the chronic coronary disease guidelines were released and consolidated prior guidelines on secondary prevention and managing stable ischemic heart disease. The role of pharmacotherapy for CCD has expanded significantly in recent decades due to emerging evidence from clinical trials and the development of novel drug therapies. This manuscript summarizes key articles and guidelines that will serve as an important resource for clinicians responsible for caring for patients with chronic coronary disease.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
01:27Coronary Artery Disease V: Interprofessional Care
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:26Angina IV: Management
01:26Atherosclerosis III: Management